Synaptic plasticity in animal models of early Alzheimer's disease

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 358, Issue 1432, 2003, Pages 821-828

  Rowan, Michael J ^a   Klyubin, Igor ^a   Cullen, William K ^a   Anwyl, Roger ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Acetylcholine; Excitatory synaptic transmission; Glutamate; Long term potentiation; NMDA receptors; amyloid

Indexed keywords

NEUROLOGY;

ANIMALIA; MUS MUSCULUS;

EID: 0037884977     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2002.1240     Document Type: Review

References (70)

1. Arendt, T. 2001 Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int. J. Dev. Neurosci. 19, 231-245.
2. Arendt, T., Brueckner, M. K., Gertz, H. J. & Marcova, L. 1998 Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurones that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83, 991-1002.
3. Ashe, K. H. 2001 Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8, 301-308.
4. Auld, D. S., Kornecook, T. J., Bastianetto, S. & Quirion, R. 2002 Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68, 209-245.
5. Barrow, P. A., Empson, R. M., Gladwell, S. J., Anderson, C. M., Killick, R., Yu, X., Jefferys, J. G. & Duff, K. 2000 Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 7, 119-126.
6. Bear, M. F. 2003 Bidirectional synaptic plasticity: from reality to theory. Phil. Trans. R. Soc. Lond. B 358, 649-655. (DOI 10.1098/rstb.2002.1255.)
7. Bi, X., Gall, C. M., Zhou, J. & Lynch, G. 2002 Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience 112, 827-840.
8. Bozon, B., Kelly, Á., Josselyn, S. A., Silva, A. J., Davis, S. & Laroche, S. 2003 MAPK, CREB and zif268 are all required for the consolidation of recognition memory. Phil. Trans. R. Soc. Lond. B 358, 805-814. (DOI 10.1098/rstb.2002.1224.)
9. Chapman, P. F., Falinska, A. M., Knevett, S. G. & Ramsay, M. F. 2001 Genes, models and Alzheimer's disease. Trends Genet. 17, 254-261.
10. Chapman, P. F. (and 11 others) 1999 Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276.
11. Chen, Q., Kagan, B. L., Hirakura, Y. & Xie, C. 2000 Impairments of hippocampal long-term potentiation by Alzheimer amyloid-β peptide. J. Neurosci. Res. 60, 65-72.
12. Chen, Q. S., Wei, W. Z., Shimahara, T. & Xie, C. W. 2002 Alzheimer amyloid β-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77, 354-371.
13. Cullen, W. R., Wu, J., Anwyl, R. & Rowan, M. J. 1996 β-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. NeuroReport 8, 87-92.
14. Cullen, W. K., Suh, Y. H., Anwyl, R. & Rowan, M. J. 1997a Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments. NeuroReport 8, 3213-3217.
15. Cullen, W. K., Anwyl, R. & Rowan, M. J. 1997b β-amyloid produces a selective block of late-phase long-term potentiation in rat hippocampus in vivo. Br. J. Pharmacol. 122, 330P.
16. Dawson, G. R. (and 11 others) 1999 Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90, 1-13.
17. Dewachter, I. (and 13 others) 2002 Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci. 22, 3445-3453.
18. Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H. & Sweatt, J. D. 2001 β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125-4133.
19. Esch, F. S., Keim, P. S., Beatie, E. C., Blacher, R. W., Culwell, A. R., Olterdoff, T., McClure, D. & Ward, P. J. 1990 Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124.
20. Fitzjohn, S. M., Morton, R. A., Davies, C. H., Seabrook, G. R. & Collingridge, G. L. 2000 Similar levels of long-term potentiation in amyloid precursor protein null and wild type mice in the CA1 region of picrotoxin treated slices. Neurosci. Lett. 288, 9-12.
21. Fitzjohn, S. M. (and 10 others) 2001 Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21, 4691-4698.
22. Frazier, C. J., Rollins, Y. D., Breese, C. R., Leonard, S., Freedman, R. & Dunwiddie, T. V. 1998 Acetylcholine activates an α-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J. Neurosci. 18, 1187-1195.
23. Freir, D. B., Holscher, C. & Herron, C. E. 2001 Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85, 708-713.
24. Giacchino, J., Criado, J. R., Games, D. & Henriksen, S. 2000 In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice. Brain Res. 876, 185-190.
25. Glenner, G. G. & Wong, C. W. 1984 Alzheimer's disease and Down's syndrome: sharing of a unique cardiovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135.
26. Hardy, J. & Selkoe, D. J. 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
27. Hédou, G. & Mansuy, I. M. 2003 Inducible molecular switches for the study of long-term potentiation. Phil. Trans. R. Soc. Lond. B358, 797-804. (DOI 10.1098/rstb.2002.1245.)
28. Hoshi, M., Takashima, A., Murayama, M., Yasutake, K., Yoshida, N., Ishiguro, K., Hoshino, T. & Imahori, K. 1997 Non-toxic amyloid β-peptide 1-42 suppresses acetylcholine synthesis. J. Biol. Chem. 272, 2038-2041.
29. Hsia, A. Y., Masliah, E., McCologue, L., Nicoll, R. A. & Mucke, L. 1999 Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228-3233.
30. Itoh, A., Akaike, T., Sokabe, M., Nitta, A. & Nabeshima, T. 1999 Impairment of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur. J. Pharmacol. 3, 167-175.
31. Janus, C., Chishti, M. & Westaway, D. 2000 Transgenic mouse models of Alzheimer's disease. Biochim. Biophys. Acta 1502, 63-75.
32. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C., Grzchik, K. H. & Muller-Hill, B. 1987 The precursor of Alzheimer's disease amyloid A4 resembles a cell surface receptor. Nature 325, 733-736.
33. Kelly, J. F., Furukawa, K., Barger, S. W., Rengen, M. R., Mark, R. J., Blanc, E. M., Roth, G. S. & Mattson, M. P. 1996 Amyloid β-peptide disrupts muscaricic transmission. Proc. Natl Acad. Sci. USA 93, 6753-6758.
34. Kim, J.-H., Anwyl, R., Suh, Y.-H., Djamgoz, M. B. & Rowan, M. J. 2001 Use-dependent effects of amyloidogenic fragments of β-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21, 1327-1333.
35. Laakso, M. P. 2002 Structural imaging in cognitive impairment and the dementias: an update. Curr. Opin. Neurol. 15, 415-421.
36. Lambert, M. P., Barlow, A. K., Chromy, B. A., Kraaft, G. A. & Klein, W. L. 1998 Diffusible nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
37. Larson, J., Lynch, G., Games, D. & Seubert, P. 1999 Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840, 23-35.
38. Lin, L. H., Bock, S., Carpenter, K., Rose, M. & Norden, J. J. 1992 Synthesis and transport of GAP-43 in entorhinal cortex of neurons and perforant pathway during lesion-induced sprouting and reactive neurogenesis. Mol. Brain Res. 14, 147-153.
39. Lisman, J. 2003 Long-term potentiation: outstanding questions/attempted synthesis. Phil. Trans. R. Soc. Lond. B 358, 829-842. (DOI 10.1098/rstb.2002.1242.)
40. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E. & Rogers, J. 1999 Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862.
41. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., Bush, A. I. & Masters, C. L. 1999 Soluble pool of A beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860-866.
42. Mesulam, M. M. 1999 Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24, 521-529.
43. Moechars, D. (and 12 others) 1999 Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483-6492.
44. Morris, R. G. M. 2003 Long-term potentiation and memory. Phil. Trans. R. Soc. Lond. B 358, 643-647. (DOI 10.1098/rstb.2002.1230.)
45. Morton, R. A., Kuenzi, F. M., Fitzjohn, S. M., Rosahl, T. W., Smith, D., Zheng, H., Shearman, M., Collingridge, G. L. & Seabrook, G. R. 2002 Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenillin-1. Neurosci. Lett. 319, 37-40.
46. Nakagami, Y. & Oda, T. 2002 Glutamate exacerbates amyloid β1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J. Pharmacol. 88, 223-226.
47. Nalbantoglu, J. (and 10 others) 1997 Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505.
48. Okuno, H., Tokuyama, W. & Miyashita, Y. 1999 Quantitative evaluation of neurotrophin and trk mRNA expression in visual and limbic areas along the occipito-tempor-hippocampal pathway in adult macaque monkeys. J. Comp. Neurol. 408, 378-398.
49. Parent, A., Linden, D. J., Sisodia, S. S. & Borchelt, D. R. 1999 Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin-1. Neurobiol. Dis. 6, 56-62.
50. Pettit, D. L., Shao, Z. & Yakel, J. L. 2001 β-Amyloid 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21, 1-5.
51. Pike, C. J., Walencewicz, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G. & Cotman, C. W. 1995 Structure-activity analyses of β-amyloid peptides: contribution of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
52. Pittenger, C. & Kandel, E. R. 2003 In search of general mechanisms for long-lasting plasticity: Aplysia and the hippocampus. Phil. Trans. R. Soc. Lond. B 358, 757-763. (DOI 10.1098/rstb.2002.1247.)
53. Richardson, J. A. & Burns, D. K. 2002 Mouse models of Alzheimer's disease: a quest for plaques and tangles. Inst. Lab. Anim. Resources J. 43, 89-99.
54. Saleshando, G. & O'Connor, J. J. 2000 SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus. Neurosci. Lett. 288, 119-122.
55. Schneider, I. (and 12 others) 2001 Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276, 11 539-11 544.
56. Seabrook, G. R. 1999 Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38, 349-359.
57. Selkoe, D. J. (and 12 others) 2002 Alzheimer's disease is a synaptic failure. Science 298, 789-791.
58. Seubert, P. (and 11 others) 1993 Secretion of β-amyloid precursor protein cleaved at the amino-terminus of the β-amyloid peptide. Nature 361, 260-263.
59. Stéphan, A., Laroche, S. & Davis, S. 2001 Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21, 5703-5714.
60. Sun, M. K. & Alkon, D. L. 2002 Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by β-amyloid(25-35). J. Neurophysiol. 87, 2441-2449.
61. Tonegawa, S., Nakazawa, K. & Wilson, M. A. 2003 Genetic neuroscience of mammalian learning and memory. Phil. Trans. R. Soc. Lond. B358, 787-795. (DOI 10.1098/rstb.2002.1243.)
62. Tong, L., Thornton, P. L., Balazs, R. & Cotman, C. W. 2001 β-Amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell suvival is not compromised. J. Biol. Chem. 276, 17 301-17 306.
63. Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., Shelanski, M. 2002 Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl Acad. Sci. USA 99, 13 217-13 221.
64. Walsh, D. M., Klyubuin, I., Fadeeva, J., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. & Selkoe, D. J. 2002 Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit long-term potentiation in vivo. Nature 416, 535-539.
65. Wang, H.-W. (and 10 others) 2002 Soluble oligomers of β-amyloid. 1-42 inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924, 133-140.
66. Wu, J., Anwyl, R. & Rowan, M. J. 1995a β-amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur. J. Pharmacol. 284, R1-R3.
67. Wu, J., Anwyl, R. & Rowan, M. J. 1995b β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippo campus. NeuroReport 6, 2409-2413.
68. Ye, L. & Qiao, J. T. 1999 Suppressive action produced by β-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci. Lett 275, 187-190.
69. Yu, H. (and 13 others) 2001 APP processing and synaptic plasticity in presenilin-1 knockout mice. Neuron 31, 713-726.
70. Zaman, S. H., Parent, A., Laskey, A., Lee, M. K., Borchelt, D. R., Sisodia, S. S. & Malinow, R. 2000 Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalised with a benzodiazapine. Neurobiol. Dis. 7, 54-63.